As of Wednesday, December 31, Greenwich LifeSciences, Inc.’s GLSI share price has dipped by 8.12%, which has investors ...
AMERICA’s BODY corporate looks, as a whole, to be in rude health. One large company after another is presenting record quarterly results. Bosses are raising profit forecasts left and right. Poke and ...
Kyle Busch has revealed that he and his wife, Samantha, lost over $8million in what he described as a life-insurance investment scheme. The couple posted a video on Tuesday to warn others of the ...
Our Fourth Annual Life Sciences Masters™ 2025 program will focus on the intersection of intellectual property and the biopharmaceutical industry, and will explore the law, politics, and business of ...
Life’s origin story just became even more mysterious. Using mathematics and information theory, Robert G. Endres of Imperial College London found that the spontaneous emergence of life from nonliving ...
Scientist Kate Adamala doesn’t remember exactly when she realized her lab at the University of Minnesota was working on something potentially dangerous — so dangerous in fact that some researchers ...
Caris Life Sciences stands out for its broad molecular and AI-driven cancer diagnostics but faces upcoming volatility as the IPO lock-up expires on 15 December 2025. CAI's revenue growth is robust, ...
Forbes contributors publish independent expert analyses and insights. Sai writes about healthcare, innovation and technology. Conceivable Life Sciences has announced a $50 million Series A round to ...
180 Life Sciences Corp (NASDAQ:ATNF) shares are soaring Tuesday after the company provided an update on its Ethereum (CRYPTO: ETH) treasury strategy. What Happened: At the end of July, 180 Life ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Frazier Life Sciences (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the closing of Frazier Life Sciences XII, L.P. (FLS ...
Frazier Life Sciences has gathered an impressive $1.3 billion in capital commitments for its 12th venture fund aimed at private early-stage biotechs. The Palo Alto-based firm said it has now raised ...
Alisha Hines graduated from an eight-week program in biomanufacturing and life sciences earning what's known as a "microcredential." (Jesse Costa/WBUR) On a recent afternoon at Northeastern University ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results